What are the major opportunities in the Choroidal Neovascularization market? What are the strategies for the Choroidal Neovascularization market?

For detailed insights on the major opportunities and strategies in the Choroidal Neovascularization market, Read More

How does the Choroidal Neovascularization market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Choroidal Neovascularization market growth and SWOT analysis of the Choroidal Neovascularization industry, Read More

For detailed insights on the mergers and acquisitions in the Choroidal Neovascularization industry,

What are the key dynamics influencing the Choroidal Neovascularization market growth? SWOT analysis of the Choroidal Neovascularization market. Read More

Global Choroidal Neovascularization Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Choroidal Neovascularization Global Market Report 2025

Name: Choroidal Neovascularization Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment Type (Anti-Angiogenic Therapy, Laser Photocoagulation, Photodynamic Therapy, Verteporfin Sodium, Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium), By Indication (Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Central Serous Chorioretinopathy (CSC), Polypoidal Choroidal Vasculopathy (PCV), Myopic Macular Degeneration (MMD), Other Indications), By Route Of Administration (Intravitreal, Subconjunctival, Periocular, Oral), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers, Research Centers) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Choroidal Neovascularization Market Overview

• Choroidal Neovascularization market size has reached to $3.88 billion in 2024

• Expected to grow to $5.59 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%

• Growth Driver: Increasing Prevalence Of Age-related Macular Degeneration Driving Market Growth

• Market Trend: Advancements In Treatment For Eye Disease With Photodynamic Therapy

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Choroidal Neovascularization Market?

Choroidal neovascularization (CNV) is the abnormal growth of blood vessels in the choroid layer of the eye, often extending into the retina. These newly formed blood vessels are fragile and prone to leaking fluid or blood, which can damage the retinal tissues, leading to vision distortion or loss.

The main treatment types of choroidal neovascularization are anti-angiogenic therapy, laser photocoagulation, photodynamic therapy, verteporfin sodium, ranibizumab, bevacizumab, aflibercept, and pegaptanib sodium. Anti-angiogenic therapy is a treatment that inhibits the formation of new blood vessels (angiogenesis), which can help prevent the growth of abnormal blood vessels. These treatments are commonly used based on the specific indications such as age-related macular degeneration (AMD), diabetic macular edema (DME), central serous chorioretinopathy (CSC), polypoidal choroidal vasculopathy (PCV), myopic macular degeneration (MMD), and other related conditions. The route of administration can vary, with options including intravitreal, subconjunctival, periocular, or oral administration. These therapies are primarily administered in hospitals, ophthalmology clinics, and ambulatory surgical centers.

Choroidal Neovascularization Market Size and growth rate 2025 to 2029: Graph

What Is The Choroidal Neovascularization Market Size 2025 And Growth Rate?

What Is The Choroidal Neovascularization Market Growth Forecast?

The choroidal neovascularization market size is expected to see strong growth in the next few years. It will grow to $5.59 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing patient awareness, growing adoption of optical coherence tomography angiography, growing demand for minimally invasive procedures, favorable reimbursement policies, and a growing geriatric population. Major trends in the forecast period include the emergence of intravitreal anti-vascular endothelial (VEGF) therapies, new gene treatments, gene therapy approaches, the adoption of telemedicine, the development of combination therapies, and personalized treatment strategies.

The forecast of 7.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. ophthalmology by inflating prices of anti-vascular endothelial growth factor(anti-VEGF) injections and optical coherence tomography systems developed in Japan and Germany, resulting in delayed age-related macular degeneration(AMD) treatment and higher retinal specialty costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Choroidal Neovascularization Market Segmented?

1) By Treatment Type: Anti-Angiogenic Therapy, Laser Photocoagulation, Photodynamic Therapy, Verteporfin Sodium, Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium

2) By Indication: Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Central Serous Chorioretinopathy (CSC), Polypoidal Choroidal Vasculopathy (PCV), Myopic Macular Degeneration (MMD), Other Indications

3) By Route Of Administration: Intravitreal, Subconjunctival, Periocular, Oral

4) By End User: Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers, Research Centers

Subsegments:

1) By Anti-Angiogenic Therapy (Anti-VEGF Therapy): Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium

2) By Laser Photocoagulation: Thermal Laser Photocoagulation, MicroPulse Laser Therapy

3) By Photodynamic Therapy (PDT): Standard PDT, Low-Fluence PDT, Half-Dose PDT

4) By Verteporfin Sodium: Intravenous Administration, Combination Therapy With Anti-VEGF

5) By Ranibizumab: Monthly Dosing, As-Needed Dosing, Treat-and-Extend Regimen

6) By Bevacizumab: Off-Label Use, Compounded Intravitreal Injections

7) By Aflibercept: Fixed-Dosing Regimen, Treat-and-Extend Regimen

8) By Pegaptanib Sodium: Monotherapy, Combination Therapy

What Is Driving The Choroidal Neovascularization Market? Increasing Prevalence Of Age-related Macular Degeneration Driving Market Growth

The rising prevalence of age-related macular degeneration (AMD) is expected to propel the growth of the choroidal neovascularization (CNV) market going forward. Age-related macular degeneration (AMD) is an eye disease that gradually damages the macula, leading to central vision loss, primarily in older adults. The rising prevalence of age-related macular degeneration (AMD) is due to the aging population, increased life expectancy, lifestyle changes, genetic factors, and greater exposure to environmental risks. Choroidal neovascularization (CNV) supports age-related macular degeneration (AMD) patients by contributing to the development of wet AMD, where the growth of abnormal blood vessels beneath the retina leads to vision deterioration, requiring advanced treatments such as anti-VEGF therapy to manage choroidal neovascularization (CNV) and slow the progression of age-related macular degeneration (AMD), ultimately preserving central vision in affected individuals. For instance, in September 2022, according to the National Institutes of Health, a US-based government agency, by 2040, age-related macular degeneration (AMD) cases may reach 300 million, and by 2050, 5.4 million Americans could be affected. Therefore, the increasing prevalence of age-related macular degeneration is driving the growth of the choroidal neovascularization industry.

Who Are The Major Players In The Global Choroidal Neovascularization Market?

Major companies operating in the choroidal neovascularization market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer Aktiengesellschaft, Novartis AG, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Chugai Pharmaceutical Co. Ltd., Alcon Inc., Genentech Inc., Bausch + Lomb Incorporated, Samsung Bioepis Co. Ltd., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Kodiak Sciences Inc., Xbrane Biopharma AB, Allergan Inc., Adverum Biotechnologies Inc., Clearside Biomedical Inc., Sylentis S.A.

What Are The Key Trends Of The Global Choroidal Neovascularization Market? Advancements In Treatment For Eye Disease With Photodynamic Therapy

Major companies operating in the choroidal neovascularization market are focusing on developing innovative therapies, such as photodynamic therapy, to provide eye care professionals with precise, efficient treatment options that improve patient outcomes and treatment delivery. Photodynamic therapy (PDT) is a medical treatment that uses a photosensitizing agent activated by light to target and destroy abnormal or cancerous cells. For instance, in February 2023, Bausch & Lomb, a Canada-based healthcare company, and Modulight, a Finland-based biomedical company, announced the ML6710i photodynamic laser approved by the Food and Drug Administration, a US-based federal agency. This therapy is approved for the use with Bausch + Lomb’s VISUDYNE therapy, designed to treat choroidal neovascularization caused by age-related macular degeneration (AMD). This modern, mobile ophthalmic laser offers a targeted approach to treating abnormal blood vessels in the eye, helping to prevent further disease progression and preserve vision.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Choroidal Neovascularization Market? Sandoz Bolsters Retinal Disease Treatment Options With CIMERLI Acquisition

In March 2024, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired CIMERLI business from Coherus for $170 Million. With this acquisition, Sandoz Group AG aims to expand its portfolio in the ophthalmic sector by acquiring the CIMERLI business from Coherus, enhancing its ability to offer innovative treatments for retinal diseases, such as age-related macular degeneration (AMD). Coherus BioSciences is a US-based biopharmaceutical company that focuses on the research and development of diseases such as choroidal neovascularization.

What Is The Regional Outlook For The Global Choroidal Neovascularization Market?

North America was the largest region in the choroidal neovascularization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Choroidal Neovascularization Market?

The choroidal neovascularization market consists of revenues earned by entities by providing services such as diagnostic services, therapeutic services, and follow-up and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The choroidal neovascularization market also includes sales of injections, therapy agents, and surgical & laser devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Choroidal Neovascularization Industry?

The choroidal neovascularization market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the choroidal neovascularization industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Choroidal Neovascularization Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.18 billion
Revenue Forecast In 2034	$5.59 billion
Growth Rate	CAGR of 7.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The choroidal neovascularization market covered in this report is segmented – 1) By Treatment Type: Anti-Angiogenic Therapy, Laser Photocoagulation, Photodynamic Therapy, Verteporfin Sodium, Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium 2) By Indication: Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Central Serous Chorioretinopathy (CSC), Polypoidal Choroidal Vasculopathy (PCV), Myopic Macular Degeneration (MMD), Other Indications 3) By Route Of Administration: Intravitreal, Subconjunctival, Periocular, Oral 4) By End User: Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers, Research Centers Subsegments: 1) By Anti-Angiogenic Therapy (Anti-VEGF Therapy): Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium 2) By Laser Photocoagulation: Thermal Laser Photocoagulation, MicroPulse Laser Therapy 3) By Photodynamic Therapy (PDT): Standard PDT, Low-Fluence PDT, Half-Dose PDT 4) By Verteporfin Sodium: Intravenous Administration, Combination Therapy With Anti-VEGF 5) By Ranibizumab: Monthly Dosing, As-Needed Dosing, Treat-and-Extend Regimen 6) By Bevacizumab: Off-Label Use, Compounded Intravitreal Injections 7) By Aflibercept: Fixed-Dosing Regimen, Treat-and-Extend Regimen 8) By Pegaptanib Sodium: Monotherapy, Combination Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer Aktiengesellschaft, Novartis AG, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Chugai Pharmaceutical Co. Ltd., Alcon Inc., Genentech Inc., Bausch + Lomb Incorporated, Samsung Bioepis Co. Ltd., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Kodiak Sciences Inc., Xbrane Biopharma AB, Allergan Inc., Adverum Biotechnologies Inc., Clearside Biomedical Inc., Sylentis S.A.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Choroidal Neovascularization Market Characteristics

3. Choroidal Neovascularization Market Trends And Strategies

4. Choroidal Neovascularization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Choroidal Neovascularization Growth Analysis And Strategic Analysis Framework

5.1. Global Choroidal Neovascularization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Choroidal Neovascularization Market Growth Rate Analysis

5.4. Global Choroidal Neovascularization Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Choroidal Neovascularization Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Choroidal Neovascularization Total Addressable Market (TAM)

6. Choroidal Neovascularization Market Segmentation

6.1. Global Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anti-Angiogenic Therapy

Laser Photocoagulation

Photodynamic Therapy

Verteporfin Sodium

Ranibizumab

Bevacizumab

Aflibercept

Pegaptanib Sodium

6.2. Global Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Age-Related Macular Degeneration (AMD)

Diabetic Macular Edema (DME)

Central Serous Chorioretinopathy (CSC)

Polypoidal Choroidal Vasculopathy (PCV)

Myopic Macular Degeneration (MMD)

Other Indications

6.3. Global Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravitreal

Subconjunctival

Periocular

Oral

6.4. Global Choroidal Neovascularization Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Ophthalmology Clinics

Ambulatory Surgical Centers

Research Centers

6.5. Global Choroidal Neovascularization Market, Sub-Segmentation Of Anti-Angiogenic Therapy (Anti-VEGF Therapy), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ranibizumab

Bevacizumab

Aflibercept

Pegaptanib Sodium

6.6. Global Choroidal Neovascularization Market, Sub-Segmentation Of Laser Photocoagulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Thermal Laser Photocoagulation

MicroPulse Laser Therapy

6.7. Global Choroidal Neovascularization Market, Sub-Segmentation Of Photodynamic Therapy (PDT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Standard PDT

Low-Fluence PDT

Half-Dose PDT

6.8. Global Choroidal Neovascularization Market, Sub-Segmentation Of Verteporfin Sodium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous Administration

Combination Therapy With Anti-VEGF

6.9. Global Choroidal Neovascularization Market, Sub-Segmentation Of Ranibizumab, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monthly Dosing

As-Needed Dosing

Treat-and-Extend Regimen

6.10. Global Choroidal Neovascularization Market, Sub-Segmentation Of Bevacizumab, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Off-Label Use

Compounded Intravitreal Injections

6.11. Global Choroidal Neovascularization Market, Sub-Segmentation Of Aflibercept, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fixed-Dosing Regimen

Treat-and-Extend Regimen

6.12. Global Choroidal Neovascularization Market, Sub-Segmentation Of Pegaptanib Sodium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monotherapy

Combination Therapy

7. Choroidal Neovascularization Market Regional And Country Analysis

7.1. Global Choroidal Neovascularization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Choroidal Neovascularization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Choroidal Neovascularization Market

8.1. Asia-Pacific Choroidal Neovascularization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Choroidal Neovascularization Market

9.1. China Choroidal Neovascularization Market Overview

9.2. China Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Choroidal Neovascularization Market

10.1. India Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Choroidal Neovascularization Market

11.1. Japan Choroidal Neovascularization Market Overview

11.2. Japan Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Choroidal Neovascularization Market

12.1. Australia Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Choroidal Neovascularization Market

13.1. Indonesia Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Choroidal Neovascularization Market

14.1. South Korea Choroidal Neovascularization Market Overview

14.2. South Korea Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Choroidal Neovascularization Market

15.1. Western Europe Choroidal Neovascularization Market Overview

15.2. Western Europe Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Choroidal Neovascularization Market

16.1. UK Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Choroidal Neovascularization Market

17.1. Germany Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Choroidal Neovascularization Market

18.1. France Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Choroidal Neovascularization Market

19.1. Italy Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Choroidal Neovascularization Market

20.1. Spain Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Choroidal Neovascularization Market

21.1. Eastern Europe Choroidal Neovascularization Market Overview

21.2. Eastern Europe Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Choroidal Neovascularization Market

22.1. Russia Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Choroidal Neovascularization Market

23.1. North America Choroidal Neovascularization Market Overview

23.2. North America Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Choroidal Neovascularization Market

24.1. USA Choroidal Neovascularization Market Overview

24.2. USA Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Choroidal Neovascularization Market

25.1. Canada Choroidal Neovascularization Market Overview

25.2. Canada Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Choroidal Neovascularization Market

26.1. South America Choroidal Neovascularization Market Overview

26.2. South America Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Choroidal Neovascularization Market

27.1. Brazil Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Choroidal Neovascularization Market

28.1. Middle East Choroidal Neovascularization Market Overview

28.2. Middle East Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Choroidal Neovascularization Market

29.1. Africa Choroidal Neovascularization Market Overview

29.2. Africa Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Choroidal Neovascularization Market Competitive Landscape And Company Profiles

30.1. Choroidal Neovascularization Market Competitive Landscape

30.2. Choroidal Neovascularization Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Choroidal Neovascularization Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Limited

31.2. Regeneron Pharmaceuticals Inc.

31.3. Astellas Pharma Inc.

31.4. Biogen Inc.

31.5. Chugai Pharmaceutical Co. Ltd.

31.6. Alcon Inc.

31.7. Genentech Inc.

31.8. Bausch + Lomb Incorporated

31.9. Samsung Bioepis Co. Ltd.

31.10. Santen Pharmaceutical Co. Ltd.

31.11. Apellis Pharmaceuticals Inc.

31.12. Kodiak Sciences Inc.

31.13. Xbrane Biopharma AB

31.14. Allergan Inc.

31.15. Adverum Biotechnologies Inc.

32. Global Choroidal Neovascularization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Choroidal Neovascularization Market

34. Recent Developments In The Choroidal Neovascularization Market

35. Choroidal Neovascularization Market High Potential Countries, Segments and Strategies

35.1 Choroidal Neovascularization Market In 2029 - Countries Offering Most New Opportunities

35.2 Choroidal Neovascularization Market In 2029 - Segments Offering Most New Opportunities

35.3 Choroidal Neovascularization Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Choroidal Neovascularization Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Choroidal Neovascularization Market, Sub-Segmentation Of Anti-Angiogenic Therapy (Anti-VEGF Therapy), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Choroidal Neovascularization Market, Sub-Segmentation Of Laser Photocoagulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Choroidal Neovascularization Market, Sub-Segmentation Of Photodynamic Therapy (PDT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Choroidal Neovascularization Market, Sub-Segmentation Of Verteporfin Sodium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Choroidal Neovascularization Market, Sub-Segmentation Of Ranibizumab, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Choroidal Neovascularization Market, Sub-Segmentation Of Bevacizumab, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Choroidal Neovascularization Market, Sub-Segmentation Of Aflibercept, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Choroidal Neovascularization Market, Sub-Segmentation Of Pegaptanib Sodium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Global Choroidal Neovascularization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Global Choroidal Neovascularization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: China, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: China, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: India, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: India, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Japan, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Japan, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Australia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Australia, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Indonesia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Indonesia, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: South Korea, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: South Korea, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Western Europe, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Western Europe, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: UK, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: UK, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Germany, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Germany, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: France, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: France, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Italy, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Italy, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Spain, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Spain, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Russia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Russia, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: North America, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: North America, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: USA, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: USA, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Canada, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Canada, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: South America, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: South America, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Brazil, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Brazil, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Middle East, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Middle East, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Africa, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 82: Africa, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 83: Pfizer Inc. Financial Performance

Table 84: Roche Holding AG Financial Performance

Table 85: AbbVie Inc. Financial Performance

Table 86: Bayer Aktiengesellschaft Financial Performance

Table 87: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Choroidal Neovascularization Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Choroidal Neovascularization Market, Sub-Segmentation Of Anti-Angiogenic Therapy (Anti-VEGF Therapy), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Choroidal Neovascularization Market, Sub-Segmentation Of Laser Photocoagulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Choroidal Neovascularization Market, Sub-Segmentation Of Photodynamic Therapy (PDT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Choroidal Neovascularization Market, Sub-Segmentation Of Verteporfin Sodium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Choroidal Neovascularization Market, Sub-Segmentation Of Ranibizumab, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Choroidal Neovascularization Market, Sub-Segmentation Of Bevacizumab, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Choroidal Neovascularization Market, Sub-Segmentation Of Aflibercept, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Choroidal Neovascularization Market, Sub-Segmentation Of Pegaptanib Sodium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Global Choroidal Neovascularization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Global Choroidal Neovascularization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: China, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: China, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: India, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: India, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Japan, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Japan, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Australia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Australia, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Indonesia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Indonesia, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: South Korea, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: South Korea, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Western Europe, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Western Europe, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: UK, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: UK, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Germany, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Germany, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: France, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: France, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Italy, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Italy, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Spain, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Spain, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Russia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Russia, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: North America, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: North America, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: USA, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: USA, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Canada, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Canada, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: South America, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: South America, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Brazil, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Brazil, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Middle East, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Middle East, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Africa, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 82: Africa, Choroidal Neovascularization Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 83: Pfizer Inc. Financial Performance

Figure 84: Roche Holding AG Financial Performance

Figure 85: AbbVie Inc. Financial Performance

Figure 86: Bayer Aktiengesellschaft Financial Performance

Figure 87: Novartis AG Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Intravascular Ultrasound Global Market Report 2025 – By Type (Platform Intravascular Ultrasound, Compact Intravascular Ultrasound), By Modality (Virtual Histology Intravascular Ultrasound (IVUS), iMap Intravascular Ultra...

Vascular Imaging Global Market Report 2025 – By Technique (Magnetic Resonance Imaging, Ultrasound, Computed Tomography, Nuclear Imaging, X-Ray), By Procedure (Coronary Angiography, Peripheral Angiography, Neurovascular A...

Ocular Hypertension Treatment Global Market Report 2025 – By Type (Intraocular Hypertension, Glaucoma), By Route of Administration (Oral, Parenteral, Other Routes), By Distribution Channel (Hospital Pharmacy, Retail Phar...

Peripheral Artery Disease Global Market Report 2025 – By Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alt...

Vascular Imaging Devices Global Market Report 2025 – By Type (Minimally Invasive, Non-Invasive), By Application (Diagnostics, Therapeutics), By End-User (Hospitals, Diagnostic Imaging Centers, Other End Users) – Impact o...

Neurovascular Embolization Devices Global Market Report 2025 – By Product (Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products), By Treatment (Ischemic Stroke Solution, Hemor...

Peripheral Arterial Disease Global Market Report 2025 – By Treatment Type (Devices, Catheters, Drugs, Other Types), By Route of Administration (Oral, Parenteral, Other Route of Administrations), By End User (Hospitals, S...

Frequently Asked Questions

What is the definition of the Choroidal Neovascularization market?

How will the Choroidal Neovascularization market drivers and restraints affect the market dynamics? What forces will shape the Choroidal Neovascularization industry going forward?

The market major growth driver - Increasing Prevalence Of Age-related Macular Degeneration Driving Market Growth. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Choroidal Neovascularization market?

The choroidal neovascularization market size has grown strongly in recent years. It will grow from $3.88 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the growing prevalence of sedentary lifestyle diseases, increasing prevalence of age-related macular degeneration, rising incidence of retinal illnesses, rising aged population, rising eye care costs, and expanding education and screening initiatives. The choroidal neovascularization market size is expected to see strong growth in the next few years. It will grow to " $5.59 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing patient awareness, growing adoption of optical coherence tomography angiography, growing demand for minimally invasive procedures, favorable reimbursement policies, and a growing geriatric population. Major trends in the forecast period include the emergence of intravitreal anti-vascular endothelial (VEGF) therapies, new gene treatments, gene therapy approaches, the adoption of telemedicine, the development of combination therapies, and personalized treatment strategies. For further insights on this market, request a sample here

How is the Choroidal Neovascularization market segmented?

The choroidal neovascularizationmarket covered in this report is segmented –
1) By Treatment Type: Anti-Angiogenic Therapy; Laser Photocoagulation; Photodynamic Therapy; Verteporfin Sodium; Ranibizumab; Bevacizumab; Aflibercept; Pegaptanib Sodium
2) By Indication: Age-Related Macular Degeneration (AMD); Diabetic Macular Edema (DME); Central Serous Chorioretinopathy (CSC); Polypoidal Choroidal Vasculopathy (PCV); Myopic Macular Degeneration (MMD); Other Indications
3) By Route Of Administration: Intravitreal; Subconjunctival; Periocular; Oral
4) By End User: Hospitals; Ophthalmology Clinics; Ambulatory Surgical Centers; Research Centers Subsegments:
1) By Anti-Angiogenic Therapy (Anti-VEGF Therapy): Ranibizumab; Bevacizumab; Aflibercept; Pegaptanib Sodium
2) By Laser Photocoagulation: Thermal Laser Photocoagulation; MicroPulse Laser Therapy
3) By Photodynamic Therapy (PDT): Standard PDT; Low-Fluence PDT; Half-Dose PDT
4) By Verteporfin Sodium: Intravenous Administration; Combination Therapy With Anti-VEGF
5) By Ranibizumab: Monthly Dosing; As-Needed Dosing; Treat-and-Extend Regimen
6) By Bevacizumab: Off-Label Use; Compounded Intravitreal Injections
7) By Aflibercept: Fixed-Dosing Regimen; Treat-and-Extend Regimen
8) By Pegaptanib Sodium: Monotherapy; Combination Therapy For further insights on this market, request a sample here

Which region has the largest share of the Choroidal Neovascularization market? What are the other regions covered in the report?

North America was the largest region in the choroidal neovascularization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the choroidal neovascularization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Choroidal Neovascularization market?

What are the key trends in the Choroidal Neovascularization market?

Major trends in this market include Advancements In Treatment For Eye Disease With Photodynamic Therapy. For further insights on this market, request a sample here.